The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice

被引:59
作者
Bell, A [1 ]
Chen, QY [1 ]
DeFrances, MC [1 ]
Michalopoulos, GK [1 ]
Zarnegar, R [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Div Cellular & Mol Pathol, Pittsburgh, PA 15261 USA
关键词
dHGF; hepatocellular carcinoma; liver; Met;
D O I
10.1038/sj.onc.1202379
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor (HGF) is a polypeptide with mitogenic, motogenic, and morphogenic effects on different cell types including hepatocytes. HGF is expressed as two biologically active isotypes resulting from alternative RNA splicing, The roles of each HGF isoform in development, liver regeneration and tumorigenesis have not yet been well characterized. We report the generation and analysis of transgenic mice overexpressing the five amino acid-deleted variant of HGF (dHGF) in the liver by virtue of an albumin expression vector. These ALB-dHGF transgenic mice develop normally, have an enhanced rate of liver regeneration after partial hepatectomy, and exhibit a threefold higher incidence of hepatocellular carcinoma (HCC) beyond 17 months of age. Moreover, overexpression of dHGF dramatically accelerates diethyl-nitrosamine induced HCC tumorigenesis, These tumors arise faster, are significantly larger, more numerous and more invasive than those appearing in non-transgenic littermates. Approximately 90% of female dHGF-transgenic mice had multiple macroscopic HCCs 40 weeks after injection of DEN; whereas the non-transgenic counterparts had only microscopic nodules, Liver tumors and cultured tumor cell lines from dHGF transgenics showed high levels of HGF and c-Met mRNA and protein, Together, these results reveal that in vivo dHGF plays an active role in liver regeneration and HCC tumorigenesis.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 50 条
[1]   Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes [J].
Amicone, L ;
Spagnoli, FM ;
Spath, G ;
Giordano, S ;
Tommasini, C ;
Bernardini, S ;
DeLuca, V ;
DellaRocca, C ;
Weiss, MC ;
Comoglio, PM ;
Tripodi, M .
EMBO JOURNAL, 1997, 16 (03) :495-503
[2]  
BLADT F, 1995, NATURE, V373, P702
[3]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[4]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[5]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[6]  
Chan A, 1993, EXS, V65, P67
[7]  
Chen QY, 1996, CELL GROWTH DIFFER, V7, P821
[8]  
Chen QY, 1997, HEPATOLOGY, V26, P59
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419
[10]  
HOGAN B, 1986, MANIPULATING MOUSE E, P174